{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T13:50:47Z","timestamp":1780408247399,"version":"3.54.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T00:00:00Z","timestamp":1694131200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T00:00:00Z","timestamp":1694131200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2024,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Marfan syndrome (MFS) is an autosomal dominant condition characterized by aortic aneurysm, skeletal abnormalities, and lens dislocation, and is caused by variants in the\n                    <jats:italic>FBN1<\/jats:italic>\n                    gene. To explore causes of MFS and the prevalence of the disease in Iceland we collected information from all living individuals with a clinical diagnosis of MFS in Iceland (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200932) and performed whole-genome sequencing of those who did not have a confirmed genetic diagnosis (27\/32). Moreover, to assess a potential underdiagnosis of MFS in Iceland we attempted a genotype-based approach to identify individuals with MFS. We interrogated deCODE genetics\u2019 database of 35,712 whole-genome sequenced individuals to search for rare sequence variants in\n                    <jats:italic>FBN1<\/jats:italic>\n                    . Overall, we identified 15 pathogenic or likely pathogenic variants in\n                    <jats:italic>FBN1<\/jats:italic>\n                    in 44 individuals, only 22 of whom were previously diagnosed with MFS. The most common of these variants, NM_000138.4:c.8038\u2009C\u2009&gt;\u2009T p.(Arg2680Cys), is present in a multi-generational pedigree, and was found to stem from a single forefather born around 1840. The p.(Arg2680Cys) variant associates with a form of MFS that seems to have an enrichment of abdominal aortic aneurysm, suggesting that this may be a particularly common feature of p.(Arg2680Cys)-associated MFS. Based on these combined genetic and clinical data, we show that MFS prevalence in Iceland could be as high as 1\/6,600 in Iceland, compared to 1\/10,000 based on clinical diagnosis alone, which indicates underdiagnosis of this actionable genetic disorder.\n                  <\/jats:p>","DOI":"10.1038\/s41431-023-01455-0","type":"journal-article","created":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T00:02:24Z","timestamp":1694131344000},"page":"44-51","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["A population-based survey of FBN1 variants in Iceland reveals underdiagnosis of Marfan syndrome"],"prefix":"10.1038","volume":"32","author":[{"given":"Elin Ola","family":"Klemenzdottir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6571-423X","authenticated-orcid":false,"given":"Gudny Anna","family":"Arnadottir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2252-4134","authenticated-orcid":false,"given":"Brynjar Orn","family":"Jensson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adalbjorg","family":"Jonasdottir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hildigunnur","family":"Katrinardottir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Run","family":"Fridriksdottir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aslaug","family":"Jonasdottir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asgeir","family":"Sigurdsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigurjon Axel","family":"Gudjonsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon Johannes","family":"Jonsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4451-3126","authenticated-orcid":false,"given":"Vigdis","family":"Stefansdottir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ragnar","family":"Danielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astridur","family":"Palsdottir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hakon","family":"Jonsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8545-3767","authenticated-orcid":false,"given":"Agnar","family":"Helgason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olafur Thor","family":"Magnusson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Unnur","family":"Thorsteinsdottir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans Tomas","family":"Bjornsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1676-864X","authenticated-orcid":false,"given":"Kari","family":"Stefansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7123-6123","authenticated-orcid":false,"given":"Patrick","family":"Sulem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,8]]},"reference":[{"key":"1455_CR1","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1056\/NEJM197904053001406","volume":"300","author":"RE Pyeritz","year":"1979","unstructured":"Pyeritz RE, McKusick VA. The Marfan syndrome: diagnosis and management. N Engl J Med. 1979;300:772\u20137.","journal-title":"N Engl J Med"},{"key":"1455_CR2","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1172\/JCI115766","volume":"89","author":"HC Dietz","year":"1992","unstructured":"Dietz HC, Pyeritz RE, Puffenberger EG, Kendzior RJ Jr., Corson GM, Maslen CL, et al. Marfan phenotype variability in a family segregating a missense mutation in the epidermal growth factor-like motif of the fibrillin gene. J Clin Invest. 1992;89:1674\u201380.","journal-title":"J Clin Invest"},{"key":"1455_CR3","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1136\/jmg.31.1.51","volume":"31","author":"JR Gray","year":"1994","unstructured":"Gray JR, Bridges AB, Faed MJ, Pringle T, Baines P, Dean J, et al. Ascertainment and severity of Marfan syndrome in a Scottish population. J Med Genet. 1994;31:51\u20134.","journal-title":"J Med Genet"},{"key":"1455_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-015-0369-8","volume":"10","author":"KA Groth","year":"2015","unstructured":"Groth KA, Hove H, Kyhl K, Folkestad L, Gaustadnes M, Vejlstrup N, et al. Prevalence, incidence, and age at diagnosis in Marfan Syndrome. Orphanet J Rare Dis. 2015;10:153.","journal-title":"Orphanet J Rare Dis"},{"key":"1455_CR5","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.mgene.2013.10.008","volume":"2","author":"A Kumar","year":"2014","unstructured":"Kumar A, Agarwal S. Marfan syndrome: An eyesight of syndrome. Meta Gene. 2014;2:96\u2013105.","journal-title":"Meta Gene"},{"key":"1455_CR6","unstructured":"Einarsson E\u00d6, Danielsen R, Sigur\u00f0sson H, Stef\u00e1nsson E. Marfans heilkenni \u00e1 \u00cdslandi. L\u00e6knabla\u00f0i\u00f0. 1996;82:557\u201362."},{"key":"1455_CR7","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.avsg.2021.12.073","volume":"82","author":"Z Wang","year":"2022","unstructured":"Wang Z, Deng X, Kang X, Hu A. Angiotensin Receptor Blockers vs. Beta-Blocker Therapy for Marfan Syndrome: A Systematic Review and Meta-Analysis. Ann Vasc Surg. 2022;82:347\u201361.","journal-title":"Ann Vasc Surg"},{"key":"1455_CR8","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.repc.2019.09.008","volume":"39","author":"SG Coelho","year":"2020","unstructured":"Coelho SG, Almeida AG. Marfan syndrome revisited: From genetics to the clinic. Rev Port Cardiol (Engl Ed). 2020;39:215\u201326.","journal-title":"Rev Port Cardiol (Engl Ed)"},{"key":"1455_CR9","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/j.amjcard.2018.06.034","volume":"122","author":"KA Groth","year":"2018","unstructured":"Groth KA, Stochholm K, Hove H, Andersen NH, Gravholt CH. Causes of Mortality in the Marfan Syndrome(from a Nationwide Register Study). Am J Cardiol. 2018;122:1231\u20135.","journal-title":"Am J Cardiol"},{"key":"1455_CR10","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1136\/jmg.2009.072785","volume":"47","author":"BL Loeys","year":"2010","unstructured":"Loeys BL, Dietz HC, Braverman AC, Callewaert BL, De Backer J, Devereux RB, et al. The revised Ghent nosology for the Marfan syndrome. J Med Genet. 2010;47:476\u201385.","journal-title":"J Med Genet"},{"key":"1455_CR11","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1002\/humu.9377","volume":"26","author":"E Arbustini","year":"2005","unstructured":"Arbustini E, Grasso M, Ansaldi S, Malattia C, Pilotto A, Porcu E, et al. Identification of sixty-two novel and twelve known FBN1 mutations in eighty-one unrelated probands with Marfan syndrome and other fibrillinopathies. Hum Mutat. 2005;26:494.","journal-title":"Hum Mutat"},{"key":"1455_CR12","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/352337a0","volume":"352","author":"HC Dietz","year":"1991","unstructured":"Dietz HC, Cutting GR, Pyeritz RE, Maslen CL, Sakai LY, Corson GM, et al. Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature 1991;352:337\u20139.","journal-title":"Nature"},{"key":"1455_CR13","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1002\/humu.9505","volume":"28","author":"P Comeglio","year":"2007","unstructured":"Comeglio P, Johnson P, Arno G, Brice G, Evans A, Aragon-Martin J, et al. The importance of mutation detection in Marfan syndrome and Marfan-related disorders: report of 193 FBN1 mutations. Hum Mutat. 2007;28:928.","journal-title":"Hum Mutat"},{"key":"1455_CR14","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0957-5839(98)80132-2","volume":"8","author":"G Stuart","year":"1998","unstructured":"Stuart G, Wilson D. Marfan syndrome: is early diagnosis useful? Curr Paediatr. 1998;8:121\u20135.","journal-title":"Curr Paediatr"},{"key":"1455_CR15","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1038\/s41436-021-01172-3","volume":"23","author":"DT Miller","year":"2021","unstructured":"Miller DT, Lee K, Chung WK, Gordon AS, Herman GE, Klein TE, et al. ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2021;23:1381\u201390.","journal-title":"Genet Med"},{"key":"1455_CR16","doi-asserted-by":"publisher","first-page":"D1062","DOI":"10.1093\/nar\/gkx1153","volume":"46","author":"MJ Landrum","year":"2018","unstructured":"Landrum MJ, Lee JM, Benson M, Brown GR, Chao C, Chitipiralla S, et al. ClinVar: improving access to variant interpretations and supporting evidence. Nucleic Acids Res. 2018;46:D1062\u2013d7.","journal-title":"Nucleic Acids Res"},{"key":"1455_CR17","unstructured":"Online Mendelian Inheritance in Men O. Johns Hopkins University, Baltimore, MD. MIM Number: 134797 Last edited: 12\/11\/2020."},{"key":"1455_CR18","unstructured":"HC. D. Marfan Syndrome. GeneReviews\u00ae [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2021: NCBI; 2001 18 [updated 2017 Oct 17]."},{"key":"1455_CR19","unstructured":"Loeys BLDH. Loeys-Dietz Syndrome. In: Adam MPED, Mirzaa GM, et al. editors, editor. GeneReviews\u00ae [Internet]. Seattle (WA): University of Washington, Seattle; 1993-20222008 28 [Updated 2018 Mar 1]. p. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1133\/."},{"key":"1455_CR20","unstructured":"B C. Congenital Contractural Arachnodactyly. In: Adam MPED, Mirzaa GM, et al. editors, editor. GeneReviews\u00ae [Internet]. Seattle (WA): University of Washington, Seattle; 1993-20222001 23 [Updated 2022 Jul 14]. p. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1386\/."},{"key":"1455_CR21","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/1523-1747.ep12286441","volume":"108","author":"LT Smith","year":"1997","unstructured":"Smith LT, Schwarze U, Goldstein J, Byers PH. Mutations in the COL3A1 gene result in the Ehlers-Danlos syndrome type IV and alterations in the size and distribution of the major collagen fibrils of the dermis. J Invest Dermatol. 1997;108:241\u20137.","journal-title":"J Invest Dermatol"},{"key":"1455_CR22","unstructured":"\u00cdslensk Erf\u00f0agreining FS Um \u00cdslendingab\u00f3k. (2003)."},{"key":"1455_CR23","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405\u201323.","journal-title":"Genet Med"},{"key":"1455_CR24","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1093\/bioinformatics\/bty897","volume":"35","author":"C Kopanos","year":"2018","unstructured":"Kopanos C, Tsiolkas V, Kouris A, Chapple CE, Albarca Aguilera M, Meyer R, et al. VarSome: the human genomic variant search engine. Bioinformatics 2018;35:1978\u201380.","journal-title":"Bioinformatics"},{"key":"1455_CR25","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/ng.3247","volume":"47","author":"DF Gudbjartsson","year":"2015","unstructured":"Gudbjartsson DF, Helgason H, Gudjonsson SA, Zink F, Oddson A, Gylfason A, et al. Large-scale whole-genome sequencing of the Icelandic population. Nat Genet. 2015;47:435\u201344.","journal-title":"Nat Genet"},{"key":"1455_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/sdata.2017.115","volume":"4","author":"H J\u00f3nsson","year":"2017","unstructured":"J\u00f3nsson H, Sulem P, Kehr B, Kristmundsdottir S, Zink F, Hjartarson E, et al. Whole genome characterization of sequence diversity of 15,220 Icelanders. Sci Data. 2017;4:170115.","journal-title":"Sci Data"},{"key":"1455_CR27","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1038\/ng.216","volume":"40","author":"A Kong","year":"2008","unstructured":"Kong A, Masson G, Frigge ML, Gylfason A, Zusmanovich P, Thorleifsson G, et al. Detection of sharing by descent, long-range phasing and haplotype imputation. Nat Genet. 2008;40:1068\u201375.","journal-title":"Nat Genet"},{"key":"1455_CR28","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1002\/(SICI)1096-8628(20000320)91:3<212::AID-AJMG12>3.0.CO;2-3","volume":"91","author":"M Palz","year":"2000","unstructured":"Palz M, Tiecke F, Booms P, G\u00f6ldner B, Rosenberg T, Fuchs J, et al. Clustering of mutations associated with mild Marfan-like phenotypes in the 3\u2032 region of FBN1 suggests a potential genotype\u2013phenotype correlation. Am J Med Genet. 2000;91:212\u201321.","journal-title":"Am J Med Genet"},{"key":"1455_CR29","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1136\/jmedgenet-2016-103996","volume":"54","author":"P Arnaud","year":"2016","unstructured":"Arnaud P, Hanna N, Aubart M, Leheup BP, Dupuis-Girod S, Naudion S, et al. Homozygous and compound heterozygous mutations in the FBN1 gene: unexpected findings in molecular diagnosis of Marfan syndrome. J Med Genet. 2016;54:100\u20133.","journal-title":"J Med Genet"},{"key":"1455_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13490","volume":"7","author":"S Benonisdottir","year":"2016","unstructured":"Benonisdottir S, Oddsson A, Helgason A, Kristjansson RP, Sveinbjornsson G, Oskarsdottir A, et al. Epigenetic and genetic components of height regulation. Nat Commun. 2016;7:13490.","journal-title":"Nat Commun"},{"key":"1455_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ajhg.2017.01.004","volume":"100","author":"QLAK Wang","year":"2017","unstructured":"Wang QLAK. InterVar: Clinical interpretation of genetic variants by ACMG-AMP 2015 guideline. Am J Hum Genet. 2017;100:1\u201314. https:\/\/doi.org\/10.1016\/j.ajhg.2017.01.004.","journal-title":"Am J Hum Genet"},{"key":"1455_CR32","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1086\/520125","volume":"81","author":"L Faivre","year":"2007","unstructured":"Faivre L, Collod-Beroud G, Loeys BL, Child A, Binquet C, Gautier E, et al. Effect of mutation type and location on clinical outcome in 1,013 probands with Marfan syndrome or related phenotypes and FBN1 mutations: an international study. Am J Hum Genet. 2007;81:454\u201366.","journal-title":"Am J Hum Genet"},{"key":"1455_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-017-0754-6","volume":"13","author":"VM Becerra-Mu\u00f1oz","year":"2018","unstructured":"Becerra-Mu\u00f1oz VM, G\u00f3mez-Doblas JJ, Porras-Mart\u00edn C, Such-Mart\u00ednez M, Crespo-Leiro MG, Barriales-Villa R, et al. The importance of genotype-phenotype correlation in the clinical management of Marfan syndrome. Orphanet J Rare Dis. 2018;13:16.","journal-title":"Orphanet J Rare Dis"},{"key":"1455_CR34","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1002\/humu.9075","volume":"20","author":"K Rommel","year":"2002","unstructured":"Rommel K, Karck M, Haverich A, Schmidtke J, Arslan-Kirchner M. Mutation screening of the fibrillin-1 (FBN1) gene in 76 unrelated patients with Marfan syndrome or Marfanoid features leads to the identification of 11 novel and three previously reported mutations. Hum Mutat. 2002;20:406\u20137.","journal-title":"Hum Mutat"},{"key":"1455_CR35","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1038\/ejhg.2009.36","volume":"17","author":"C Stheneur","year":"2009","unstructured":"Stheneur C, Collod-Beroud G, Faivre L, Buyck JF, Gouya L, Le Parc JM, et al. Identification of the minimal combination of clinical features in probands for efficient mutation detection in the FBN1 gene. Eur J Hum Genet. 2009;17:1121\u20138.","journal-title":"Eur J Hum Genet"},{"key":"1455_CR36","first-page":"8","volume":"57","author":"G Nijbroek","year":"1995","unstructured":"Nijbroek G, Sood S, McIntosh I, Francomano CA, Bull E, Pereira L, et al. Fifteen novel FBN1 mutations causing Marfan syndrome detected by heteroduplex analysis of genomic amplicons. Am J Hum Genet. 1995;57:8\u201321.","journal-title":"Am J Hum Genet"},{"key":"1455_CR37","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1002\/ajmg.a.37085","volume":"167a","author":"W Wooderchak-Donahue","year":"2015","unstructured":"Wooderchak-Donahue W, VanSant-Webb C, Tvrdik T, Plant P, Lewis T, Stocks J, et al. Clinical utility of a next generation sequencing panel assay for Marfan and Marfan-like syndromes featuring aortopathy. Am J Med Genet A 2015;167a:1747\u201357.","journal-title":"Am J Med Genet A"},{"key":"1455_CR38","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1161\/CIRCULATIONAHA.111.030379","volume":"124","author":"S Svensj\u00f6","year":"2011","unstructured":"Svensj\u00f6 S, Bj\u00f6rck M, G\u00fcrtelschmid M, Djavani Gidlund K, Hellberg A, Wanhainen A. Low prevalence of abdominal aortic aneurysm among 65-year-old Swedish men indicates a change in the epidemiology of the disease. Circulation 2011;124:1118\u201323.","journal-title":"Circulation"},{"key":"1455_CR39","doi-asserted-by":"publisher","first-page":"D1207","DOI":"10.1093\/nar\/gkaa1043","volume":"49","author":"S K\u00f6hler","year":"2021","unstructured":"K\u00f6hler S, Gargano M, Matentzoglu N, Carmody LC, Lewis-Smith D, Vasilevsky NA, et al. The Human Phenotype Ontology in 2021. Nucleic Acids Res. 2021;49:D1207\u201317.","journal-title":"Nucleic Acids Res"},{"key":"1455_CR40","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1016\/j.jvs.2008.12.007","volume":"49","author":"T Takayama","year":"2009","unstructured":"Takayama T, Miyata T, Nagawa H. True abdominal aortic aneurysm in Marfan syndrome. J Vasc Surg. 2009;49:1162\u20135.","journal-title":"J Vasc Surg"},{"key":"1455_CR41","first-page":"65","volume":"9","author":"J Ker","year":"2015","unstructured":"Ker J. Interatrial septal aneurysm with mitral valve prolapse in a patient with Marfan syndrome-a caveat of note. Int J Cardiol Heart Vasc. 2015;9:65\u20136.","journal-title":"Int J Cardiol Heart Vasc"},{"key":"1455_CR42","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1111\/cge.13640","volume":"97","author":"A Najafi","year":"2020","unstructured":"Najafi A, Caspar SM, Meienberg J, Rohrbach M, Steinmann B, Matyas G. Variant filtering, digenic variants, and other challenges in clinical sequencing: a lesson from fibrillinopathies. Clin Genet. 2020;97:235\u201345.","journal-title":"Clin Genet"},{"key":"1455_CR43","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1038\/gim.2016.181","volume":"19","author":"KA Groth","year":"2017","unstructured":"Groth KA, Von Kodolitsch Y, Kutsche K, Gaustadnes M, Thorsen K, Andersen NH, et al. Evaluating the quality of Marfan genotype-phenotype correlations in existing FBN1 databases. Genet Med. 2017;19:772\u20137.","journal-title":"Genet Med"},{"key":"1455_CR44","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/s10038-021-00899-w","volume":"66","author":"A Gezdirici","year":"2021","unstructured":"Gezdirici A, Teral\u0131 K, G\u00fclec EY, Bornaun H, Dogan M, Er\u00f6z R. An integrated clinical and molecular study of a cohort of Turkish patients with Marfan syndrome harboring known and novel FBN1 variants. J Hum Genet. 2021;66:647\u201357.","journal-title":"J Hum Genet"},{"key":"1455_CR45","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1038\/gim.2018.27","volume":"20","author":"R Weerakkody","year":"2018","unstructured":"Weerakkody R, Ross D, Parry DA, Ziganshin B, Vandrovcova J, Gampawar P, et al. Targeted genetic analysis in a large cohort of familial and sporadic cases of aneurysm or dissection of the thoracic aorta. Genet Med. 2018;20:1414\u201322.","journal-title":"Genet Med"},{"key":"1455_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/srep33002","volume":"6","author":"H Yang","year":"2016","unstructured":"Yang H, Luo M, Fu Y, Cao Y, Yin K, Li W, et al. Genetic testing of 248 Chinese aortopathy patients using a panel assay. Sci Rep. 2016;6:33002.","journal-title":"Sci Rep"},{"key":"1455_CR47","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.ymgme.2014.03.011","volume":"112","author":"JP Lerner-Ellis","year":"2014","unstructured":"Lerner-Ellis JP, Aldubayan SH, Hernandez AL, Kelly MA, Stuenkel AJ, Walsh J, et al. The spectrum of FBN1, TGF\u03b2R1, TGF\u03b2R2 and ACTA2 variants in 594 individuals with suspected Marfan Syndrome, Loeys\u2013Dietz Syndrome or Thoracic Aortic Aneurysms and Dissections (TAAD). Mol Genet Metab. 2014;112:171\u20136.","journal-title":"Mol Genet Metab"},{"key":"1455_CR48","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/j.1399-0004.2011.01771.x","volume":"82","author":"S Sheikhzadeh","year":"2012","unstructured":"Sheikhzadeh S, Kade C, Keyser B, Stuhrmann M, Arslan-Kirchner M, Rybczynski M, et al. Analysis of phenotype and genotype information for the diagnosis of Marfan syndrome. Clin Genet. 2012;82:240\u20137.","journal-title":"Clin Genet"},{"key":"1455_CR49","first-page":"1229","volume":"14","author":"T Deng","year":"2008","unstructured":"Deng T, Dong B, Zhang X, Dai H, Li Y. Late-onset bilateral lens dislocation and glaucoma associated with a novel mutation in FBN1. Mol Vis. 2008;14:1229\u201333.","journal-title":"Mol Vis"},{"key":"1455_CR50","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1111\/j.1469-1809.2009.00545.x","volume":"73","author":"CC Hung","year":"2009","unstructured":"Hung CC, Lin SY, Lee CN, Cheng HY, Lin SP, Chen MR, et al. Mutation spectrum of the fibrillin-1 (FBN1) gene in Taiwanese patients with Marfan syndrome. Ann Hum Genet. 2009;73:559\u201367.","journal-title":"Ann Hum Genet"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41431-023-01455-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-023-01455-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-023-01455-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,7]],"date-time":"2024-01-07T19:04:38Z","timestamp":1704654278000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41431-023-01455-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,8]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["1455"],"URL":"https:\/\/doi.org\/10.1038\/s41431-023-01455-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2085746\/v1","asserted-by":"object"}]},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,8]]},"assertion":[{"value":"20 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Authors affiliated with deCODE Genetics\/Amgen declare competing interests as employees. HTB is a Consultant for Mahzi therapeutics. The remaining authors declare no competing financial interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The case series study (patient identifiers) was approved by the Icelandic Ethics Committee (V\u00edsindasi\u00f0anefnd). The database study (no patient identifiers) has prior approval by the Icelandic Ethics Committee (V\u00edsindasi\u00f0anefnd) but all participating individuals, or their guardians, have given informed consent prior to participation. All sample identifiers are encrypted in accordance with the regulations of the Icelandic Data Protection Authority. No single person was simultaneously able to access data with or without identifiers. Approval for these studies was provided by the National Bioethics Committee and the Icelandic Data Protection Authority.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}